How should a patient with incidentally discovered non‑obstructing renal stones on ultrasound be managed?

Management of Non-Obstructing Renal Stones Discovered on Ultrasound

For patients with incidentally discovered non-obstructing renal stones on ultrasound, active surveillance is appropriate for asymptomatic stones, with imaging follow-up and metabolic evaluation reserved for high-risk patients or those with stone growth/symptoms. 1

Initial Evaluation

When non-obstructing renal stones are discovered, perform the following assessment:

• Detailed medical and dietary history focusing on:

  • Prior stone episodes or family history of stones
  • Medications or supplements that promote stones (calcium/vitamin D supplements, topiramate, protease inhibitors)
  • Fluid intake patterns and specific beverages consumed
  • Dietary sodium, protein, calcium, and high-oxalate food intake 2

• Serum chemistries: electrolytes, calcium, creatinine, and uric acid to identify metabolic abnormalities 2

• Urinalysis with microscopy: assess pH, look for infection indicators, and identify pathognomonic crystals (cystine, struvite) 2

• Quantify stone burden by reviewing imaging to assess:

  • Number of stones (multiple/bilateral stones increase recurrence risk)
  • Stone size and location
  • Presence of nephrocalcinosis (suggests underlying metabolic disorder) 2

Risk Stratification

High-risk patients requiring more intensive evaluation and follow-up include those with:

• Recurrent stone formers
• Solitary kidney
• Multiple or bilateral stones
• Large stone burden
• Nephrocalcinosis
• Suspected metabolic disorders (hypercalcemia suggesting hyperparathyroidism)
• Recurrent UTIs with stones 2

Metabolic Testing

Perform 24-hour urine collection (preferably two collections) in high-risk or interested first-time stone formers, analyzing for:

• Total volume, pH, calcium, oxalate, uric acid, citrate, sodium, potassium, creatinine
• Add cystine measurement if cystine stones suspected or family history present 2

Imaging Follow-Up Strategy

The 2025 EAU guidelines provide specific discharge timeframes based on stone characteristics 1:

For stone-free patients after treatment:

• Radiopaque stones: discharge from imaging after 2 years (80% safety margin) or 5 years (90% safety margin)
• Radiolucent stones: discharge after 3 years (80% safety margin) or 5 years (90% safety margin)

For untreated asymptomatic stones:

• Use ultrasound or KUB X-ray for radiopaque stones to minimize radiation 1
• Reserve CT for stone growth, new symptoms, or hydronephrosis on ultrasound
• High-risk patients on medical management: follow for at least 4 years; discharge if nonprogressive
• Patients not on prophylactic medication: consider lifelong follow-up due to high recurrence risk 1

Conservative Management vs. Intervention

Observation is appropriate when:

• Stones are asymptomatic and non-obstructing
• Particularly for lower pole stones (less likely to cause symptoms or pass spontaneously) 3, 4
• No infection present
• Patient has normal contralateral kidney function

Natural history data shows that during 3+ years of surveillance 3:

• 28% of stones become symptomatic
• 7% pass spontaneously
• <20% require surgical intervention
• Upper pole/mid-renal stones more likely to become symptomatic (40.6%) or pass (14.5%) compared to lower pole stones (24.3% symptomatic, 2.9% passage)

Critical Pitfall: Silent Obstruction

Important caveat: Approximately 2-3% of asymptomatic non-obstructing stones can cause painless silent obstruction over time 3, 5. This emphasizes the importance of periodic imaging surveillance rather than complete abandonment of follow-up, particularly in patients with:

• Solitary kidney
• Bilateral stones
• Baseline renal impairment

Dietary Recommendations for All Stone Formers

Implement these measures regardless of stone composition 2:

• Fluid intake: achieve urine volume ≥2.5 liters daily (most critical intervention)
• Sodium restriction: limit to ≤2,300 mg (100 mEq) daily
• Calcium intake: maintain recommended dietary allowance (avoid both deficiency and excess supplementation)
• Protein moderation: limit excessive animal protein
• Increase fruits and vegetables: provides alkali load and citrate

Beneficial beverages: coffee (caffeinated/decaffeinated), tea, wine, orange juice, alcohol in moderation Avoid: sugar-sweetened beverages 2

Indications for Intervention

Proceed to surgical treatment if 6:

• Stone growth documented on serial imaging
• Development of symptoms (pain, hematuria)
• Recurrent UTIs attributable to stones
• Obstruction develops
• Patient preference after shared decision-making

Follow-Up Intervals

For asymptomatic stones under observation:

• Initial follow-up imaging at 6 months
• If stable, extend to annual imaging 7
• Adjust frequency based on stone size, location, and patient risk factors
• Consider metabolic re-evaluation if stone growth occurs